The demand for anticancer drugs is rising in Asia

In the face of the risk of cancer explosion in the future, the demand for analgesics and anti-cancer drugs is also increasing in Asia.

Currently, new pharmacists have invented a number of new anti-cancer drugs, based on the biochemical mechanism of cancer cells. Transmission methods that are both expensive and painful for patients are likely to be replaced by Roche's cancer drugs, Herceptin and Avastin or Gleevec of Novartis.

However, economically, for Asians, these anti-cancer analgesic drugs seem to be too ' luxurious '. Michael Rawlins, chairman of the British National Institute of Pathology, said that with increasing demand in Asia, the price of this cancer medicine is too high compared to the standard of living and the average income in the region. .

Lung cancer is a major problem in Asia, with an additional 600,000 people suffering from this disease each year.Smoking is considered the main cause of this disease.(Photo: VTC)

According to a recent report from the World Health Organization, in just one more decade, the number of people suffering from cancer in Asia will skyrocket. Cancer of the lungs, stomach and liver are the highest incidence of cancer in Asia. Next is breast cancer and colon inflammation.

The total number of cancers in Asia is likely to increase from 4.5 million in 2002 to 7.1 million by 2020 without interventions. Lung cancer is the biggest problem in Asia, with 600,000 more people suffering from this disease each year. Smoking is considered the main cause of this disease. In some Asian countries, more than 60% of men smoke.

Hoài Thư